Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Net Cash Flow (2020 - 2025)

RxSight's Net Cash Flow history spans 6 years, with the latest figure at -$9.7 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 26952.78% year-over-year to -$9.7 million; the TTM value through Dec 2025 reached $3.2 million, down 54.11%, while the annual FY2025 figure was $3.2 million, 54.11% down from the prior year.
  • Net Cash Flow reached -$9.7 million in Q4 2025 per RXST's latest filing, up from -$10.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $29.6 million in Q2 2022 to a low of -$43.7 million in Q4 2021.
  • Average Net Cash Flow over 5 years is $313200.0, with a median of -$68500.0 recorded in 2023.
  • Peak YoY movement for Net Cash Flow: skyrocketed 5507.54% in 2021, then crashed 26952.78% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$43.7 million in 2021, then skyrocketed by 106.55% to $2.9 million in 2022, then tumbled by 106.05% to -$173000.0 in 2023, then skyrocketed by 120.81% to $36000.0 in 2024, then plummeted by 26952.78% to -$9.7 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Net Cash Flow are -$9.7 million (Q4 2025), -$10.7 million (Q3 2025), and $12.3 million (Q2 2025).